Online first
Short communication
Published online: 2024-09-13
Patent foramen ovale closure for stroke prevention
Pubmed: 39377624
Abstract
Not available
References
- Health Needs Map in the scope of hospital Treatment for Poland (30.08.2018). http://www.mz.gov.pl/wp-content/uploads/2016/04/17_polska-1.pdf (accessed: June 18, 2024).
- Mohan KM, Wolfe CDA, Rudd AG, et al. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke. 2011; 42(5): 1489–1494.
- Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with PFO. Eur Heart J. 2019; 40(38): 3182–3195.
- Benvenuti F, Meucci F, Vuolo L, et al. Relation between the size of patent foramen ovale and the volume of acute cerebral ischemic lesion in young patients with cryptogenic ischemic stroke. Neurol Sci. 2022; 43(1): 453–458.
- Araszkiewicz A, Bartuś S, Demkow M, et al. Interventional closure of patent foramen ovale in prevention of thromboembolic events. Consensus document of the Association of Cardiovascular Interventions and the Section of Grown‑up Congenital Heart Disease of the Polish Cardiac Society. Kardiol Pol. 2019; 77(11): 1094–1105.
- Diener HC, Chutinet A, Easton JD, et al. Dabigatran or aspirin after embolic stroke of undetermined source in patients with patent foramen ovale: Results from RE-SPECT ESUS. Stroke. 2021; 52(3): 1065–1068.
- Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017; 377(11): 1033–1042.
- Kasner SE, Rhodes JF, Andersen G, et al. Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2021; 384(10): 970–971.
- Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017; 377(11): 1022–1032.
- Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale. J Am Coll Cardiol. 2018; 71(20): 2335–2342.
- Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014; 370(15): 1393–1401.
- Angelini F, Fortuni F, Tsivgoulis G, et al. Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: An updated meta-analysis. Cardiovasc Drugs Ther. 2021; 35(5): 987–993.
- Błażejewska-Hyżorek B. Guidelines for the management of stroke. Pol Neurol Rev . 2019; 15.
- Kent DM, Saver JL, Ruthazer R, et al. Risk of Paradoxical Embolism (RoPE)-estimated attributable fraction correlates with the benefit of patent foramen ovale closure: An analysis of 3 trials. Stroke. 2020; 51(10): 3119–3123.
- Nachoski D, Schroeder J, Almalla M, et al. Dual-center experiences with interventional closure of patent foramen ovale: A medium-term follow-up study comparing two patient groups aged under and over 60 years. Clin Cardiol. 2021; 44(3): 386–391.
